Immunotherapy after surgery helped reduce cancer recurrence in patients with urothelial cancer of the bladder or other sites in the urinary tract that had invaded the muscle and therefore posed a high risk for recurrence, ...
May 15, 2022
0
108
As tissue slides are more routinely digitized to aid interpretation, a software program whose design was led by the University of Michigan Health System is proving its utility.
Jan 13, 2012
0
0
Why are some bladder cancers resistant to a type of immunotherapy called immune checkpoint inhibitors? Penn State College of Medicine researchers have found that the genetic and pathologic diversity of cells within the tumor ...
Mar 31, 2023
0
37
A combination immunotherapy treatment of nivolumab plus ipilimumab was associated with no improvement in survival for advanced cancers other than melanoma, when compared to nivolumab alone, according to a recent Northwestern ...
Sep 22, 2023
0
59
Beagles aren't just one of America's most popular dog breeds. According to new research from North Carolina State University, they're also key to new findings about the chromosomal changes associated with urothelial carcinoma, ...
Apr 27, 2015
0
136
Chemotherapy is indicated as the first line of treatment for advanced bladder cancer. New research by Weill Cornell Medicine and University of Trento scientists shows that while chemotherapy kills the most common type of ...
Oct 18, 2016
0
55
UC San Diego Health is now offering a new treatment for patients with low-grade upper tract urothelial cancer (LG-UTUC) that could safely avoid removal of the entire kidney, which may prevent the need for dialysis or kidney ...
Oct 20, 2022
0
8
A phase 3 clinical trial co-led by Mount Sinai researchers is the first to show that immunotherapy after surgery to remove bladder cancer can reduce the risk of relapse for patients who are at high risk of their cancer returning ...
Jun 2, 2021
0
2
The antiangiogenic drug pazopanib has demonstrated clinically meaningful activity in patients with refractory urothelial cancer, according to results presented at the AACR Annual Meeting 2012, held here March 31 - April 4. ...
Apr 1, 2012
0
0
A new research paper titled "Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior" has been published in Oncotarget.
Mar 22, 2023
0
2
